Correlation between time to progression and overall survival in patients with metastatic breast cancer

被引：1
|
作者：
Sherrill, B.
Hirst, C.
Wu, Y.
Amonkar, M. M.
Stein, S.
机构：
[1] RTI Hlth Solut, Res Triangle Pk, NC USA
[2] RTI Hlth Solut, Manchester, Lancs, England
[3] GlaxoSmithKline Inc, Collegeville, PA USA
来源：
VALUE IN HEALTH | 2007年 / 10卷 / 03期
关键词：
D O I：
10.1016/S1098-3015(10)68914-0
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A123 / A124
页数：2
相关论文
共 50 条
  • [1] Overall survival and time to disease progression improved in metastatic breast cancer patients
    不详
    ONCOLOGY-NEW YORK, 2004, 18 (03): : 338 - 338
  • [2] Retrospective pooled analysis to assess correlation between time to progression and overall survival in patients with breast cancer
    Sherrill, B.
    Hirst, C.
    Wu, Y.
    Amonkar, M.
    Stein, S. H.
    BREAST, 2007, 16 : S54 - S54
  • [3] Relationship between effects on time-to-disease progression and overall survival in studies of metastatic breast cancer
    B Sherrill
    M Amonkar
    Y Wu
    C Hirst
    S Stein
    M Walker
    J Cuzick
    British Journal of Cancer, 2008, 99 : 1572 - 1578
  • [4] Relationship between effects on time-to-disease progression and overall survival in studies of metastatic breast cancer
    Sherrill, B.
    Amonkar, M.
    Wu, Y.
    Hirst, C.
    Stein, S.
    Walker, M.
    Cuzick, J.
    BRITISH JOURNAL OF CANCER, 2008, 99 (10) : 1572 - 1578
  • [5] Impact on overall survival and progression free survival of local treatment in patients with metastatic breast cancer
    Maffuz-Aziz, Antonio
    Aldaneli Arredondo-Rodriguez, Bibiana
    Labastida-Almendaro, Sonia
    Alberto Tenorio-Torres, Juan
    Carbajal-Saldana, Brenda
    Rodriguez-Cuevas, Sergio
    GACETA MEXICANA DE ONCOLOGIA, 2014, 13 (02): : 106 - 111
  • [6] Factors Associated with Time to Progression and Overall Survival in Patients with De Novo Metastatic Breast Cancer: A Colombian Cohort
    Esperanza Diaz-Casas, Sandra
    Briceno-Morales, Ximena
    Juliana Puerto-Horta, Leidy
    Lehmann-Mosquera, Carlos
    Cecilia Orozco-Ospino, Martha
    Hernan Guzman-AbiSaab, Luis
    Angel-Aristizabal, Javier
    Garcia-Mora, Mauricio
    Alfonso Duarte-Torres, Carlos
    Fernando Marino-Lozano, Ivan
    Briceno-Morales, Clara
    Sanchez-Pedraza, Ricardo
    ONCOLOGIST, 2022, 27 (02): : E142 - E150
  • [7] PROGRESSION-FREE SURVIVAL AS A SURROGATE FOR OVERALL SURVIVAL IN METASTATIC BREAST CANCER
    Beauchemin, C.
    Cooper, D.
    Lapierre, M.
    Yelle, L.
    Lachaine, J.
    ANNALS OF ONCOLOGY, 2012, 23 : 119 - 120
  • [8] PROGRESSION-FREE SURVIVAL AS A SURROGATE FOR OVERALL SURVIVAL IN METASTATIC BREAST CANCER
    Beauchemin, C.
    Cooper, D.
    Lapierre, M. E.
    Yelle, L.
    Lachaine, J.
    VALUE IN HEALTH, 2012, 15 (07) : A414 - A414
  • [9] Correlation between progression free survival and overall survival in patients with metastatic breast cancer receiving anthracyclines, taxanes or targeted therapies: A trial level meta-analysis.
    Adunlin, Georges
    Dranitsaris, George
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [10] Progression-free survival as a potential surrogate for overall survival in metastatic breast cancer
    Beauchemin, Catherine
    Cooper, Dan
    Lapierre, Marie-Eve
    Yelle, Louise
    Lachaine, Jean
    ONCOTARGETS AND THERAPY, 2014, 7 : 1101 - 1110
12345